Gerald Feuer, MD
Gynecologic Oncology · Atlanta, GANPI 1275509515
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.8%), consulting fees and education — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by AstraZeneca at 48.9% of the total.
Across 225 payments — averaging $452.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$50K
- Baxter Healthcare$43K
- Intuitive Surgical$6K
- Merck$354
- Pfizer$296
- GSK$276
- plus $2K from 28 others
What the payments were for
- Consulting fees$24,50524%
- Speaking & faculty fees$48,57548%
- Travel & lodging$2,9713%
- Food & beverage$6,0326%
- Education$19,43919%
- Gifts$2000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 72 | $49,756 |
| Baxter Healthcare | 26 | $43,453 |
| Intuitive Surgical | 19 | $5,952 |
| Merck | 18 | $354 |
| Pfizer | 13 | $296 |
| GSK | 11 | $276 |
| Myriad Genetic Laboratories, Inc. | 6 | $195 |
| Eisai Inc. | 8 | $181 |
| Conmed Corporation | 1 | $178 |
| Clovis Oncology, Inc. | 10 | $176 |
| Seagen Inc. | 7 | $157 |
| Asensus Surgical, Inc. | 1 | $117 |
| Tesaro, Inc. | 5 | $100 |
| AbbVie | 3 | $61 |
| BD | 1 | $53 |
| Integra Lifesciences Corporation | 2 | $50 |
| Astellas Pharma US Inc | 2 | $48 |
| Novartis | 1 | $31 |
| Kyowa Kirin, Inc. | 2 | $30 |
| Covidien LP | 2 | $28 |
| Coherus Oncology, Inc. | 2 | $26 |
| Immunogen, Inc. | 1 | $21 |
| Dilon Technologies, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Solventum Corporation | 1 | $17 |
| LSI Solutions Inc | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Acell, Inc. | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $15 |
| Medtronic | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Convatec Inc. | 1 | $13 |
| Davol Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$48,856
- PerClot$22,179
- TISSEEL$21,556
- Da Vinci Surgical System$4,952
- DAVINCI XI$750
- FLOSEAL$725
- STARLING SYSTEM$138
- Senhance Surgical Robotics System$117
- SEPRAFILM$103
How this compares
$101,722 in reported general payments places this provider in the 85th percentile of 49 gynecologic oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 61 | $230 |
| Metronidazole | 53 | $102 |
| Tramadol Hcl | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Atlanta
- Benedict BenignoAtlanta$273K
- Adam PyrzakAtlanta$116K
- Guilherme CantuariaAtlanta$13K
- Cyril SpannAtlanta$12K
- Kevin AultAtlanta$10K
- Leda GattocAtlanta$7K
- Jennifer ScaliciAtlanta$6K
- Oi Wah YapAtlanta$3K
- Namita KhannaAtlanta$3K
- Joseph BoveriAtlanta$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.